Nebenwirkungen · Isturisa
Isturisa 1 mg film-coated tablets Isturisa 5 mg film-coated tablets Isturisa 10 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 7
HOS-142185 · Präparat HOS-098768
Adverse reactions (Table 1) are listed by MedDRA system organ class. Within each system organ class, the adverse reactions are ranked by frequency, with the most frequent reactions first. Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness. In addition, the corresponding frequency category for each adverse reaction is based on the following convention: very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1 000 to < 1/100); rare (≥ 1/10 000 to < 1/1 000); very rare (< 1/10 000).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2024-12-12T15:32:00Z · SHA-256 13107ffe0035bb183c6ee6076a8db3da498ecb30795369b80b898d43d73d46cc · Passage 10f7ed7f82322c7456e9d64ebcceff1496a3a6fc475ce0bfde6bfa08d7ddfab7 · Zeichen 660–1200 im Abschnitt